Home > Compound List > Product Information
Atorvastatin-d5 Lactone_Molecular_structure_CAS_)
Click picture or here to close

Atorvastatin-d5 Lactone

Catalog No. A791782 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C33H33FN2O4 Telephone +1 (416) 665-9696
M. W. 540.6245232 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer, Under Inert Atmosphere Chembase ID: 160744

SYNONYMS

IUPAC name
5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-4-(2H5)phenyl-N-phenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide
IUPAC Traditional name
5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-2-isopropyl-4-(2H5)phenyl-N-phenylpyrrole-3-carboxamide
Synonyms
Atorvastatin-d5 δ-Lactone
5-(4-Fluorophenyl)-2-(1-methylethyl)-N-phenyl-(4-phenyl-d5)-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide

DATABASE IDS

PROPERTIES

Certificate of Analysis Download
Apperance Light Yellow Solid
Melting Point 98-100°C
Solubility DMF
Solubility DMSO
Solubility Ethyl Acetate
Solubility Methanol
MSDS Link Download
Storage Condition -20°C Freezer, Under Inert Atmosphere

DETAILS

Description (English)
Labelled Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation.

REFERENCES

  • Boyd, R., et al.: J. Clin. Pharmacol., 40, 91, (2000)
  • Bogman, K., et al.: Br. J. Pharmacol., 132, 1183 (2000)
  • Backman, J., et al.: Clin. Pharmacol. Ther., 72, 685 (2000)
  • Kalvass, J., et al.: Drug Metab. Dispos., 35, 455 (2000)